Alcami Finalizes Acquisition of Pacific Pharmaceutical Services on the West Coast
Thursday, January 18, 2024
Alcami Corporation, a leading contract development and manufacturing organization (CDMO), has announced the successful completion of its acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a provider of cGMP pharma storage and services.
According to Bill Humphries, the CEO of Alcami, the acquisition of Pacific Pharmaceutical Services is a strategic move to enhance the capabilities of their pharma storage and services business. The strategic West Coast location of PPS will enable Alcami to better cater to the bicoastal market, improve material safeguarding from natural disasters, and support multi-center clinical trials. This acquisition solidifies Alcami's position as the leading U.S. CDMO for West Coast projects, focusing on stability and security in the storage of pre-clinical and clinical materials.
In addition to the PPS acquisition, Alcami is expanding its central North Carolina pharma storage and service footprint with a new 65,000 square foot facility near the Research Triangle Park's biotech and pharma hub. This expansion, combined with the acquisition, highlights Alcami's commitment to its comprehensive pharma storage and services business.
Pacific Pharmaceutical Services, known for personalized and responsive customer care, provides controlled storage and material management solutions, clinical labeling, and support for various stages of development. Scott Chadwick, the founder of PPS, will continue as the General Manager and Site Head.
This collaboration will provide PPS clients with access to Alcami's extensive service offerings, from analytical development to full drug product development and manufacturing. Similarly, Alcami's clients will gain access to PPS' West Coast cGMP pharma storage capacity and support services, ensuring a seamless experience across the Alcami network of laboratory, pharma storage, and manufacturing services.
Source: prnewswire.com
